Geyser Brands: Canadian LP Rolling Up Cannabis Brands
Tony Deyes
May 2nd, 2019
App, Exclusive, News, Top News
Geyser Brands Inc. (TSXV: GYSR) is a Health Canada-approved Licensed Producer based in Vancouver, BC, actively engaged in building a leading cannabis healthcare company with a diverse portfolio of products and brands in the lucrative health & wellness industry, including a range of products to promote pet health and wellness.
Solace Acquisition Provides Established Brands
To that end, the company announced the intended acquisition of Solace Management Group Inc. and its portfolio of brands, ranging from the medical and adult recreational cannabis markets to pet health & wellness, including Apawthecary, Canada’s leading hemp-infused pet brand. Solace’s goal is to set the bar for consumer healthcare using cannabis-infused products emphasizing quality, effectiveness, reliability, and convenience. Geyser Brands and Solace have entered into an LOI as of February 2019, and are expected to close the transaction in Q2 2019.
Solace was initially inspired by Gabriele Jerousek, co-founder of Solace and an advocate for the benefits of medical cannabis who grew up helping her grandmother heal people with custom formulated tinctures, healing herbs, and topicals in her Viennese apothecary. Today, she is the CEO of Solace’s subsidiary Apothecary Naturals
Under the Solace umbrella, the Apawthecary brand alone produces human-grade, all-natural hemp-based pet treats, salves, and oral drops currently sold in over 400 pet stores and 100 veterinary clinics across Canada. Solace has also developed WildTails, the first freeze-dried pet food infused with hemp and, where legal, CBD. This new brand addresses pet wellness with treats, kibble, and food for dogs and cats, and is scheduled for release in Canada, the US, UK, and Japan later this year. Pet health & wellness is a $132 billion dollar industry, and is projected to be among the fastest growing sectors of the red hot hemp and CBD market, with products aimed at conditions such as anxiety and inflammation leading the pet health segment.
Click here to see the company corporate presentation
Apothecary Naturals is a line of 100% natural hemp-based topical products, pain creams, cosmetics, organic soaps, lip balms, and men’s grooming and self-care products, handmade in small batches without chemicals, fillers, or hidden ingredients. Apothecary Ink is a line of all-natural hemp-based tattoo aftercare products.
Apothecary Labs is Solace’s research and development arm, engaged in technology and formulation development for beverages, topicals, cosmetics, and other cannabis and hemp-infused nutraceutical products. Apothecary’s caplets, tinctures, and buccal sprays are condition-based, and formulated, produced, and tested by its team of scientists and researchers.
Click here to see the company corporate presentation
The Solace acquisition is expected to usher in the foundation of a diverse domestic and international cannabis-powered consumer healthcare brand portfolio with equity in medical, pet, cosmeceutical, and nutraceutical markets. Net revenue for Solace’s fiscal year ended December 31, 2018 was just under $2 million, reflecting a 120% increase over net revenue for the previous year, due in large part to distribution agreements throughout 2018.
Brandeavour to Maximize Brand Direction
Geyser intends to take Solace’s brands global through retail and digital direct-to-consumer sales, launching its hemp-infused cannabis brands and products in the U.S., EU, and Asia, and its CBD-infused line of products in jurisdictions where CBD is legal.
To prepare for this, the company recently announced the appointment of London-based Brandeavour to provide strategic branding and brand direction to Geyser Brands and its subsidiaries. Anthony Webb, brand expert/strategist, and founder of Brandeavour, will serve as the company’s consultant of record for strategic branding and creative counsel. Webb has worked with some of the world’s leading brands, and consulted for international bodies such as the Danish Embassy, the Barbados High Commission, Jamaican High Commission, and the Commonwealth Secretariat. Brandeavour will work alongside Geyser Brands’ strategic partner, GetFresh Ventures, to provide data-driven digital growth services and develop new channels to market Geyser Brands.
Click here to see the company corporate presentation
Commenting on the appointment, Geyser Brands CEO Andreas Thatcher said, “The Geyser Brands team is thrilled to have Anthony on board and working to support our business and brand growth. Anthony is an old friend and confidant, and his global experience with consumers across all industries, from luxury products and retail to sports and entertainment, gives him a perspective into consumer needs and preferences that are rivaled by few in the industry. Combined with the data-driven digital strategy frameworks supported by GetFresh Ventures, we are perfectly positioned to develop a compelling, highly differentiated, and consumer-focused approach to brand growth and development.”
The company is currently negotiating non-binding letters of intent with a number of U.S. brands seeking Canadian distribution, and negotiating joint ventures with entities in China and Japan for the commercialization of its hemp products. Stay tuned for updates.
Geyser Celebrates First Harvest, Champions NanoFusion Technology
The company announced at the end of March that its 7,000 sq ft. licensed facility in Port Coquitlam, BC has completed the first harvest, and has been certified compliant with Health Canada standards, moving it a step closer to receiving its processing and sales license. The company is also developing its manufacturing and R&D capabilities at the facility to provide in-house formulated products for future brands and Geyser’s white label products. The harvest provides the first revenue from the cultivation license, while expanded licensing will allow Geyser to manufacture CBD extracts and bring its extract-infused products to market.
The lessons learned during the first harvest are expected to help produce an even bigger yield from successive crops, and the company will continue to invest in the development of unique, high-quality proprietary strains and technologies to address health conditions such as chronic pain and inflammation, digestive issues, insomnia, and other common ailments.
Click here to see the company corporate presentation
Geyser Brands’ trademarked Nanofusion technology, for example (which goes into all of its products) are nano-emulsions that encapsulate oil molecules to solve the problem of CBD’s insolubility, enabling more effective, accurate dosing. The efficacy of most hemp products is restricted by the insoluble nature of the molecules, which prevents most of the product from permeating the skin or entering the body system. Nanofusion increases shelf stability and improves bioavailability, skin permeation, while faster onsets and slow releases means consumers require lower doses to achieve optimal health & wellness benefits.
Geyser Brands offers a ground floor opportunity with a company on the cusp of big developments, the potential for rapid growth, and a detailed plan for expansion and the promotion of its diverse offering.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Tony Deyes
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Hero Technologies Inc. is a cannabis company working toward a vertically-integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis […]
The Green Organic Dutchman Holdings Ltd. is a premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe and Latin America and the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
